1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
(
- Contribution to journal › Article
-
Mark
Apolipoproteins and the risk of giant cell arteritis—a nested case–control study
(
- Contribution to journal › Article
- 2022
-
Mark
An update on polymyalgia rheumatica
(
- Contribution to journal › Scientific review
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
(
- Contribution to journal › Article
-
Mark
Pathogenesis of giant cell arteritis with focus on cellular populations
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Cardiovascular drug treatment, statins and biopsy-confirmed giant cell arteritis : a population-based case-control study
(
- Contribution to journal › Article
-
Mark
Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis
(
- Contribution to journal › Article
- 2016
-
Mark
The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis
(
- Contribution to journal › Article
-
Mark
Visual complications in patients with biopsy-proven giant cell arteritis : A population-based study
(
- Contribution to journal › Article